The other face of facioscapulohumeral muscular dystrophy: Exploring orofacial weakness using muscle ultrasound
- PMID: 39297366
- DOI: 10.1002/mus.28254
The other face of facioscapulohumeral muscular dystrophy: Exploring orofacial weakness using muscle ultrasound
Abstract
Introduction/aims: One of the most distinct clinical features of facioscapulohumeral muscular dystrophy (FSHD) is facial weakness. It leads to diminished facial expression and functional impairments. Despite its clinical relevance, little else is known about orofacial muscle involvement. We therefore evaluated orofacial muscle involvement in a sizeable cohort of FSHD participants with muscle ultrasound.
Methods: Muscle ultrasound images of the following orofacial muscles were scored visually and quantitatively: depressor anguli oris (DAO), orbicularis oris (OO), buccinator, temporalis, masseter, digastric, zygomaticus major and minor bilaterally, and the geniohyoid. Reliability analyses of both visual and quantitative evaluations were performed. Ultrasound results were correlated with other measures: the FSHD clinical score, facial weakness score, and facial function scale.
Results: We included 107 FSHD participants (male 54%; age 52 ± 14 years), of whom 92% showed signs of facial weakness. The reliability of visual ultrasound analysis varied widely (κ 0.0-1.0). Quantitative ultrasound reliability was high (intraclass correlation analysis ≥ 0.96). The DAO, buccinator, OO, temporalis, and zygomaticus minor muscles were affected most often (15%-39%). The digastric, geniohyoid, zygomaticus major, and masseter muscles were least often affected (<5%). The ultrasound compound score correlated weakly to moderately with other outcome measures used (ρ = 0.3-0.7).
Discussion: This study adds to the understanding of orofacial weakness in FSHD, confirming the involvement of the muscles of facial expression in FSHD using ultrasound. We showed that orofacial muscle ultrasound is feasible and reliable when quantitatively assessed. Future studies should evaluate orofacial muscle ultrasound longitudinally, alongside clinical and patient-reported facial weakness outcome measures, to assess their potential as outcome measures.
Keywords: biomarker; facial function; facial weakness; facioscapulohumeral muscular dystrophy; ultrasound.
© 2024 The Author(s). Muscle & Nerve published by Wiley Periodicals LLC.
References
REFERENCES
-
- Mul K, Lassche S, Voermans NC, Padberg GW, Horlings CGC, van Engelen BGM. What's in a name? The clinical features of facioscapulohumeral muscular dystrophy. Pract Neurol. 2016;16(3):201‐207.
-
- Mul K, Berggren KN, Sills MY, et al. Effects of weakness of orofacial muscles on swallowing and communication in FSHD. Neurology. 2019;92(9):e957‐e963.
-
- Loonen T, Horlings C, Vincenten S, et al. Characterizing the face in facioscapulohumeral muscular dystrophy. J Neurol. 2021;268:1342‐1350.
-
- van de Geest‐Buit WA, Rasing NB, Mul K, et al. Facing facial weakness: psychosocial outcomes of facial weakness and reduced facial function in facioscapulohumeral muscular dystrophy. Disabil Rehabil. 2023;45(15):2507‐2516.
-
- Rasing NB, van de Geest‐Buit W, Chan OYA, et al. Psychosocial functioning in patients with altered facial expression: a scoping review in five neurological diseases. Disabil Rehabil. 2024;46:3772‐3791.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
